価格表

在庫・価格 : 2024年04月20日 12時19分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
CytoSelect 96-well Cell Transformation Assay (96assays)
データシート
CBA-130 CBOセルバイオラボ
Cell Biolabs. Inc.
1 kit ¥176,000
(未発注)
追加

在庫・価格 : 2024年04月20日 12時19分 現在

CytoSelect 96-well Cell Transformation Assay (96assays)

  • 商品コード:CBA-130
  • メーカー:CBO
  • 包装:1kit
  • 価格: ¥176,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Gomes-Giacoia E et al. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol. Cancer Ther. 2013 Dec;12(12):2697-708
Gomes-Giacoia E et al
2013/01/01
PubMed
2 Kegelman TP et al. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro-oncology 2014 Jan;16(1):50-61
Kegelman TP et al
2014/01/01
PubMed
3 Hatano K et al. Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. Mol. Cancer Res. 2013 Sep;11(9):1088-100
Hatano K et al
2013/01/01
PubMed
4 Gupta P et al. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis. Carcinogenesis 2013 Feb;34(2):388-96
Gupta P et al
2013/01/01
PubMed
5 Xing C et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol. Cancer Ther. 2013 Jan;12(1):94-103
Xing C et al
2013/01/01
PubMed
6 Ghantous A et al. Inhibition of tumor promotion by parthenolide: epigenetic modulation of p21. Cancer Prev Res (Phila) 2012 Nov;5(11):1298-309
Ghantous A et al
2012/01/01
PubMed
7 Dennis M et al. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2012 Oct;147(4):726-32
Dennis M et al
2012/01/01
PubMed
8 Tan X et al. cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc. Natl. Acad. Sci. U.S.A. 2012 Sep;109(39):15805-10
Tan X et al
2012/01/01
PubMed
9 Maccario C et al. The resveratrol analog 4,4"-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells. Carcinogenesis 2012 Nov;33(11):2172-80
Maccario C et al
2012/01/01
PubMed
10 Maag D et al. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc. Natl. Acad. Sci. U.S.A. 2011 Jan;108(4):1391-6
Maag D et al
2011/01/01
PubMed
11 Lin L et al. A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling. Cancer Discov 2014 Oct;4(10):1168-81
Lin L et al
2014/01/01
PubMed
12 Zecchini V et al. Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 2014 Jun;33(12):1365-82
Zecchini V et al
2014/01/01
PubMed
13 Eisfeld AK et al. NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc. Natl. Acad. Sci. U.S.A. 2014 Mar;111(11):4179-84
Eisfeld AK et al
2014/01/01
PubMed
14 Gong J et al. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Clin. Cancer Res. 2014 Mar;20(5):1259-73
Gong J et al
2014/01/01
PubMed
15 Rai V et al. Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. J. Exp. Med. 2012 Dec;209(13):2339-50
Rai V et al
2012/01/01
PubMed
16 Inami Y et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 2011 Apr;193(2):275-84
Inami Y et al
2011/01/01
PubMed
17 Carnahan J et al. Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growth. Mol. Cancer Ther. 2010 Aug;9(8):2399-410
Carnahan J et al
2010/01/01
PubMed
18 Liu F et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010 Jun;29(25):3650-64
Liu F et al
2010/01/01
PubMed
19 Iorns E et al. The role of SATB1 in breast cancer pathogenesis. J. Natl. Cancer Inst. 2010 Aug;102(16):1284-96
Iorns E et al
2010/01/01
PubMed
20 Faoro L et al. EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J. Biol. Chem. 2010 Jun;285(24):18575-85
Faoro L et al
2010/01/01
PubMed
21 Rubio R et al. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res. 2010 May;70(10):4185-94
Rubio R et al
2010/01/01
PubMed
22 Takezawa K et al. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells. Cancer Res. 2009 Aug;69(16):6515-21
Takezawa K et al
2009/01/01
PubMed
23 Li H et al. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer Ther. 2009 Jun;8(6):1692-701
Li H et al
2009/01/01
PubMed
24 Kang MI et al. A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits". Mol. Cancer Ther. 2009 Mar;8(3):571-81
Kang MI et al
2009/01/01
PubMed
25 Wei Q et al. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(50):19738-43
Wei Q et al
2008/01/01
PubMed
26 Shen L et al. E1A inhibits the proliferation of human cervical cancer cells (HeLa cells) by apoptosis induction through activation of HER-2/Neu/Caspase-3 pathway. Med. Oncol. 2008;25(2):222-8
Shen L et al
2008/01/01
PubMed
27 Lee KB et al. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp. Mol. Med. 2008 Feb;40(1):118-29
Lee KB et al
2008/01/01
PubMed
28 Gazin C et al. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007 Oct;449(7165):1073-7
Gazin C et al
2007/01/01
PubMed
  • No.: 1
  • 文献情報:
    Gomes-Giacoia E et al. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol. Cancer Ther. 2013 Dec;12(12):2697-708
    Gomes-Giacoia E et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kegelman TP et al. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro-oncology 2014 Jan;16(1):50-61
    Kegelman TP et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hatano K et al. Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. Mol. Cancer Res. 2013 Sep;11(9):1088-100
    Hatano K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gupta P et al. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis. Carcinogenesis 2013 Feb;34(2):388-96
    Gupta P et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Xing C et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol. Cancer Ther. 2013 Jan;12(1):94-103
    Xing C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ghantous A et al. Inhibition of tumor promotion by parthenolide: epigenetic modulation of p21. Cancer Prev Res (Phila) 2012 Nov;5(11):1298-309
    Ghantous A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Dennis M et al. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2012 Oct;147(4):726-32
    Dennis M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Tan X et al. cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc. Natl. Acad. Sci. U.S.A. 2012 Sep;109(39):15805-10
    Tan X et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Maccario C et al. The resveratrol analog 4,4"-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells. Carcinogenesis 2012 Nov;33(11):2172-80
    Maccario C et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Maag D et al. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc. Natl. Acad. Sci. U.S.A. 2011 Jan;108(4):1391-6
    Maag D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lin L et al. A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling. Cancer Discov 2014 Oct;4(10):1168-81
    Lin L et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zecchini V et al. Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 2014 Jun;33(12):1365-82
    Zecchini V et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Eisfeld AK et al. NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc. Natl. Acad. Sci. U.S.A. 2014 Mar;111(11):4179-84
    Eisfeld AK et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Gong J et al. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Clin. Cancer Res. 2014 Mar;20(5):1259-73
    Gong J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Rai V et al. Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. J. Exp. Med. 2012 Dec;209(13):2339-50
    Rai V et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Inami Y et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 2011 Apr;193(2):275-84
    Inami Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Carnahan J et al. Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growth. Mol. Cancer Ther. 2010 Aug;9(8):2399-410
    Carnahan J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Liu F et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010 Jun;29(25):3650-64
    Liu F et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Iorns E et al. The role of SATB1 in breast cancer pathogenesis. J. Natl. Cancer Inst. 2010 Aug;102(16):1284-96
    Iorns E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Faoro L et al. EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J. Biol. Chem. 2010 Jun;285(24):18575-85
    Faoro L et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Rubio R et al. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res. 2010 May;70(10):4185-94
    Rubio R et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Takezawa K et al. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells. Cancer Res. 2009 Aug;69(16):6515-21
    Takezawa K et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Li H et al. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer Ther. 2009 Jun;8(6):1692-701
    Li H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Kang MI et al. A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits". Mol. Cancer Ther. 2009 Mar;8(3):571-81
    Kang MI et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Wei Q et al. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(50):19738-43
    Wei Q et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Shen L et al. E1A inhibits the proliferation of human cervical cancer cells (HeLa cells) by apoptosis induction through activation of HER-2/Neu/Caspase-3 pathway. Med. Oncol. 2008;25(2):222-8
    Shen L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Lee KB et al. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp. Mol. Med. 2008 Feb;40(1):118-29
    Lee KB et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Gazin C et al. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007 Oct;449(7165):1073-7
    Gazin C et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed